Home World News How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early... World News How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? By Ogkologos - November 3, 2026 43 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research MOST POPULAR A 27-Year-Old Woman Passed Away. The Note She Wrote The Day... June 19, 2019 Beating the Heat with Beets July 31, 2020 The Power of Fruits and Vegetables December 18, 2020 Immunotherapy Plus Chemotherapy Helps People With Advanced Nasopharyngeal Cancer: The ASCO... April 18, 2022 Load more HOT NEWS Genetic Counseling for Hereditary Breast Cancer: What People With a Family... Liquid Biopsy Detects Brain Cancer and Early-Stage Kidney Cancer Toothbrushes and ctDNA: Exciting early detection concepts from new teams formed... First Mature Estimation of Median OS for Selpercatinib in Patients with...
